CIP
BLFS icon

Cornerstone Investment Partners’s BioLife Solutions BLFS Stock Holding History

Cornerstone Investment Partners’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$384K Sell
13,605
-646
-5% -$15.1K 0.01% 131
2026
Q1 		$272K Buy
+14,251
New +$315K 0.01% 181
2020
Q1 		– Sell
-10,365
Closed -$168K – 176
2019
Q4 		$168K Buy
+10,365
New +$169K 0.01% 180

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Cornerstone Investment Partners's BLFS Position: Q2 2026 in Review

Cornerstone Investment Partners reduced its BioLife Solutions (BLFS) stake by 4.5% in Q2 2026, selling an estimated $15.1K and leaving 13,605 shares worth $384K. The position accounts for 0.01% of the portfolio, ranked #131.

Cornerstone Investment Partners first reported a position in BLFS in Q4 2019 and has held it in 3 quarters since. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Cornerstone Investment Partners held 13,605 shares of BioLife Solutions worth $384K as of Q2 2026.
  • Cornerstone Investment Partners sold 646 BioLife Solutions shares in Q2 2026, an estimated $15.1K.
  • BioLife Solutions made up 0.01% of Cornerstone Investment Partners's portfolio in Q2 2026, its #131 holding.
  • Cornerstone Investment Partners first reported a position in BioLife Solutions in Q4 2019 and has held it in 3 quarters since.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Cornerstone Investment Partners's 13F filing for Q2 2026, filed 7 Aug 2026.